This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Mar 15;371(9616):873-4.

doi: 10.1016/S0140-6736(08)60389-X.

Biodegradable drug-eluting stents: promises and pitfalls

Carlo Di Mario¹, Giuseppe Ferrante

Affiliations

PMID: 18342665
DOI: 10.1016/S0140-6736(08)60389-X

Comment

Biodegradable drug-eluting stents: promises and pitfalls

Carlo Di Mario et al. Lancet. 2008.

. 2008 Mar 15;371(9616):873-4.

doi: 10.1016/S0140-6736(08)60389-X.

Authors

Carlo Di Mario¹, Giuseppe Ferrante

Affiliation

¹ Royal Brompton Hospital, Imperial College, London SW3 6NP, UK. c.dimario@rbht.nhs.uk

PMID: 18342665
DOI: 10.1016/S0140-6736(08)60389-X

No abstract available

PubMed Disclaimer

Comment on

A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial.
Ormiston JA, Serruys PW, Regar E, Dudek D, Thuesen L, Webster MW, Onuma Y, Garcia-Garcia HM, McGreevy R, Veldhof S. Ormiston JA, et al. Lancet. 2008 Mar 15;371(9616):899-907. doi: 10.1016/S0140-6736(08)60415-8. Lancet. 2008. PMID: 18342684 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science